Study Stopped
UTSW Family Medicine refused to comply with agreement to implement study after department head left university. Attempts to implement elsewhere failed.
Electronic-Measurement Based Care for Major Depressive Disorder
e-MBC
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The pilot study will evaluate whether electronic-Measurement Based Care (e-MBC) using the UT Southwestern MyChart personal health record is feasible, associated with patient and health care team satisfaction, and improves treatment outcomes compared to a standard treatment model. The project will be conducted in the Simmons Cancer Center Clinic at the University of Texas Southwestern Medical Center, Dallas as a collaborative effort between the Departments of Psychiatry, Oncology, and Family and Community Medicine. The primary patient population will include adults with significant depression and/or starting an antidepressant treatment and/or experiencing a treatment change. The study will compare two groups, an e-MBC group and an office-based standard care MBC group. Study staff will explain the study to the patients, specifically explaining that study participants will receive either office-based MBC or e-MBC. Eligible participants must be willing to receive either form of treatment monitoring. Participating patients will be randomly assigned to receive either e-MBC or office-based MBC. In the e-MBC group once a month the study nurse will send a prompt from the participating patients treating physician requesting the patient to use the MyChart system to fill-out the MBC scales. Beyond these monthly assessments, patients will be encouraged to utilize the MyChart MBC assessments (e-MBC) at any time to communicate with their physician. Patients experiencing difficulties using the e-MBC system will be given additional instruction by the study nurse. Patients and physicians will be trained in the use of the eMBC system. In the office-based MBC group the study nurse will schedule monthly treatment visits and request the patient call as needed to report symptoms. The evaluation period will be 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2011
Longer than P75 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 19, 2012
CompletedFirst Posted
Study publicly available on registry
April 24, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedFebruary 5, 2019
February 1, 2019
5.5 years
April 19, 2012
February 2, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient Health Questionnaire (PHQ-9)
Depression severity assessment
Every 30 days for 6 months
Secondary Outcomes (4)
Frequency, Intensity, and Burden of Side Effect Rating (FIBSER)
Every 30 days for 6 months
Patient Satisfaction Questionnaire (PSQ)
At the end of study treament (6 months from the first assessment)
Physician Evaluation of Ease of Use Survey (EEUS)
At the end of study treament (6 months from the first assessment)
Physician Evaluation of Usefulness Survey (EUS)
At the end of study treament (6 months from the first assessment)
Study Arms (2)
e-MBC
ACTIVE COMPARATORPatients will receive e-MBC
Treatment as Usual Control
NO INTERVENTIONPatients receive standard treatment
Interventions
Eligibility Criteria
You may qualify if:
- Patients must plan to continue living in the clinic area throughout the study
- Patients must be 18 to 65 years of age
- Patients must give written informed consent
- Patient must have clinically significant depression and/or starting an antidepressant treatment and/or experiencing a antidepressant treatment change
- Patients must be willing and able to use MyChart to communicate with their physician
You may not qualify if:
- Patients with a current Axis I diagnosis of Bipolar disorder or Schizophrenia
- Patients who cannot read and understand English since all research instruments are not yet translated and validated in Spanish or other languages
- Patients whose clinical status requires inpatient treatment at the time of baseline interview.
- Current substance abuse or dependence
- Patients with current suicidal ideation
- Patients with general medical conditions that contraindicate antidepressant medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
April 19, 2012
First Posted
April 24, 2012
Study Start
June 1, 2011
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
February 5, 2019
Record last verified: 2019-02